Christina Huerta-Stylianou
Research Mentor: Yuji Mishina
Mentor Department: Biological and Material Sciences, Dentistry
Author(s): Not Available
Session: Afternoon Session (12:00 PM – 1:00 PM)
Presentation Type: Oral Presentation
Abstract
This study investigates the role of osteoblast-osteoclast (OB-OC) coupling in regulating bone formation and explores how chemical modulation of this interaction may enhance osteoblast activity. Bone homeostasis depends on a balance between osteoblast-mediated bone formation and osteoclast-driven resorption, with direct cell-cell communication playing a key role in coordinating these processes. Previous findings suggest that direct contact between osteoblasts and osteoclasts suppresses osteoblast function, identifying this interaction as a potential therapeutic target. To examine this, in vitro co-culture systems were used to evaluate the effects of clinically relevant compounds, including Edaravone and Prednisone, across a range of concentrations, with mineralization assessed using Alizarin Red staining. Edaravone-treated samples were compromised due to contamination, preventing reliable interpretation of its effects on osteoblast activity. In contrast, Prednisone-treated groups produced consistent staining across concentrations in both osteoblast-only and co-culture conditions, suggesting minimal or no significant impact on osteoblast mineralization under the conditions tested, or errors involving osteoclast viability. These findings show the importance of experimental reliability and indicate that prednisone may not strongly modulate OB-OC coupling in this model. Future work will focus on quantitative mineralization analysis and in-vivo studies to further evaluate candidate compounds, such as BIX-02188 and clarify their effects on bone formation.
